1. Home
  2. SPRO vs GEOS Comparison

SPRO vs GEOS Comparison

Compare SPRO & GEOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.79

Market Cap

135.5M

Sector

Health Care

ML Signal

HOLD

Logo Geospace Technologies Corporation (Texas)

GEOS

Geospace Technologies Corporation (Texas)

HOLD

Current Price

$8.26

Market Cap

134.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
GEOS
Founded
2013
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
135.5M
134.5M
IPO Year
2017
1997

Fundamental Metrics

Financial Performance
Metric
SPRO
GEOS
Price
$2.79
$8.26
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
663.0K
243.9K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
111.81
N/A
EPS
N/A
N/A
Revenue
$66,802,000.00
$110,803,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$300.00
N/A
P/E Ratio
N/A
N/A
Revenue Growth
39.24
N/A
52 Week Low
$1.80
$5.86
52 Week High
$3.09
$29.89

Technical Indicators

Market Signals
Indicator
SPRO
GEOS
Relative Strength Index (RSI) 55.64 43.31
Support Level $2.18 $7.45
Resistance Level $2.90 $8.85
Average True Range (ATR) 0.17 0.59
MACD 0.03 0.10
Stochastic Oscillator 58.45 39.31

Price Performance

Historical Comparison
SPRO
GEOS

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About GEOS Geospace Technologies Corporation (Texas)

Geospace Technologies Corp is engaged in designing and manufacturing sophisticated technology solutions for applications in smart water management, energy exploration, as well as industrial and Internet of Things. Its seismic equipment is used to locate, characterize, and monitor hydrocarbon reservoirs and is also marketed for vibration monitoring, security, and geotechnical uses. The company also produces non-seismic products such as Hydroconn cables, imaging equipment, remote shutoff water valves, and IoT platforms, and provides contract manufacturing services. The company's business segments includes Smart Water, Energy Solutions and Intelligent Industrial. The majority of its revenue is generated from the Energy Solutions segment.

Share on Social Networks: